Format

Send to

Choose Destination
See comment in PubMed Commons below
Cell. 2010 Apr 2;141(1):13-7. doi: 10.1016/j.cell.2010.03.018.

It's diagnostics, stupid.

Author information

1
Division of Molecular Carcinogenesis, Center for Biomedical Genetics and Cancer Genomics Center, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. r.bernards@nki.nl

Abstract

To stem the spiraling cost of cancer treatment, a concerted effort is urgently needed to develop molecular diagnostics to better identify the patients that respond to expensive targeted therapies. Opportunities and obstacles in the development of such drug response biomarkers are discussed here.

PMID:
20371338
DOI:
10.1016/j.cell.2010.03.018
[Indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center